1. Home
  2. IRON vs NIC Comparison

IRON vs NIC Comparison

Compare IRON & NIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

N/A

Current Price

$63.61

Market Cap

3.1B

Sector

Health Care

ML Signal

N/A

Logo Nicolet Bankshares Inc.

NIC

Nicolet Bankshares Inc.

N/A

Current Price

$163.62

Market Cap

3.5B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
IRON
NIC
Founded
2017
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
3.5B
IPO Year
2020
2002

Fundamental Metrics

Financial Performance
Metric
IRON
NIC
Price
$63.61
$163.62
Analyst Decision
Strong Buy
Buy
Analyst Count
13
6
Target Price
$103.17
★ $191.80
AVG Volume (30 Days)
★ 444.2K
115.1K
Earning Date
11-05-2026
10-20-2026
Dividend Yield
N/A
★ 0.88%
EPS Growth
N/A
★ 21.49
EPS
N/A
★ 3.56
Revenue
N/A
N/A
Revenue This Year
N/A
$74.17
Revenue Next Year
N/A
$8.51
P/E Ratio
★ N/A
$45.98
Revenue Growth
N/A
N/A
52 Week Low
$40.00
$114.12
52 Week High
$99.50
$180.00

Technical Indicators

Market Signals
Indicator
IRON
NIC
Relative Strength Index (RSI) 31.11 31.07
Support Level $65.04 $143.19
Resistance Level $72.68 $162.06
Average True Range (ATR) 2.42 3.53
MACD -0.21 -0.73
Stochastic Oscillator 22.75 0.00

Price Performance

Historical Comparison
IRON
NIC

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

About NIC Nicolet Bankshares Inc.

Nicolet Bankshares Inc is a United States-based bank holding company's principal business is banking, consisting of lending and deposit gathering, as well as ancillary banking-related products and services, to businesses and individuals of the communities it serves, and the operational support to deliver, fund and manage. It offers a variety of loans, deposits, and related services to business customers especially small and medium-sized businesses and professional concerns, business deposit products, cash management services, international banking services, business loans, lines of credit, commercial real estate financing, construction loans, agricultural real estate or production loans, and letters of credit, as well as retirement plan services.

Share on Social Networks: